A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases

American Journal of Roentgenology

Volumn 189, Issue 5, 2007, Pages 1199-1202

  Khandani, Amir H ^a,b   Calvo, Benjamin F ^a,b   O'Neil, Bert H ^a,b   Jorgenson, Jennifer ^a   Mauro, Matthew A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

FDG PET; Liver cancer; Liver metastasis; Metastases; Oncologic imaging; Radiofrequency ablation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; MALE; MINIMAL RESIDUAL DISEASE; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

ADULT; AGED; CATHETER ABLATION; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 35648963659     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.2126     Document Type: Article

References (10)

1. Weber WA. Positron emission tomography as an imaging biomarker. J Clin Oncol 2006; 24:3282-3292
2. McGahana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR 2001; 176:3-16
3. Antoch G, Vogt FM, Veit P, et al. Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med 2005; 46:520-525
4. Tsuda M, Rikimaru H, Majima K, et al. Time-related changes of radiofrequency ablation lesion in the normal rabbit liver: findings of magnetic resonance imaging and histopathology. Invest Radiol 2003; 38:525-531
5. McGahan JP, Brock JM, Tesluk H, Gu WZ, Schneider P, Browning PD. Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol 1992; 3:291-297
6. Donckier V, Van Laethem JL, Goldman S, et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 2003; 84:215-223
7. Langenhoff BS, Oyen WJ, Jager GJ, et al. Efficacy of fluorine-18- deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 2002; 20:4453-4458
8. Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 2003; 28:192-197
9. Veit P, Antoch G, Stergar H, Bockisch A, Forsting M, Kuehl H. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol 2006; 16:80-87
10. Halpern BS, Dahlbom M, Quon A, et al. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. J Nucl Med 2004; 45:797-801